Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Ardea Biosciences Inc. (working on small-molecule therapeutics for gout, HIV, and cancer) has netted $157.6mm through the follow-on offering of 9.8mm common shares (including the overallotment) at $17 each. Part of the proceeds will support ongoing Phase III trials of the company's lead candidate lesinurad for gout.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?